News

November 13, 2019
November 13, 2019

Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply

Do you like it?
Read more
November 7, 2019
November 7, 2019

StageBio and Alizée Pathology Merge

Do you like it?
Read more
October 31, 2019
October 31, 2019

Mesa Labs Acquires Gyros Protein Technologies

Do you like it?
Read more
October 30, 2019
October 30, 2019

Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific

Do you like it?
Read more
October 17, 2019
October 17, 2019

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

Do you like it?
Read more
October 7, 2019
October 7, 2019

New England Peptide Receives Growth Equity Investment From Ampersand Capital Partners

Do you like it?
Read more
September 30, 2019
September 30, 2019

N2 Biomedical Appoints Victor Nunes and Dean Schauer to Board of Directors

Do you like it?
Read more
July 15, 2019
July 15, 2019

Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

Do you like it?
Read more
June 18, 2019
June 18, 2019

Ampersand Completes Growth Equity Investment in N2 Biomedical

Do you like it?
Read more
June 6, 2019
June 6, 2019

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

Do you like it?
Read more
Prev page
1234...11
Next page